As Synageva is taken over by Alexion, its entry to the domestic market become vague

The American pharmaceutical company, Synageva, has encountered difficulties in expansion to the Korean market.

According to the industry concerned on the 24^th, a pharmaceutical companies specializing in rare and incurable diseases, Synageva Biopharma, was working on a process to launch its domestic corporate, finishing to recruit a Korean CEO recently.

However, as an American company, Alexion...